RT Journal Article
T1 Relationship between nutritional treatment compliance and nutritional status improvements in patients with gastrointestinal impairment taking an oral peptide-based supplement.
A1 López-Medina, José A
A1 López-Rodriguez, Cristóbal
A1 Estornell-Gualde, María A
A1 Rey-Fernández, Laura
A1 Gómez-Senent, Silvia
A1 Joaquín-Ortiz, Clara
A1 Fernández-Soto, M Luisa
A1 Hurtado-García, Roberto
A1 Martín-Martín, Margarita
A1 Barrera-Martín, Ana
A1 Vitales-Farrero, M Teresa
A1 Martínez-Ortega, Antonio J
A1 Blanca-Martínez-Barbeito, María
A1 Vázquez-Vizcaíno, Begoña
A1 Tasende-Fernández, Clara
A1 Penacho-Lázaro, M Ángeles
A1 Jordá-Sorolla, Esther
A1 Sánchez-Sánchez, Rebeca
A1 Díaz-Gómez, Laura
A1 Baos-Fernández, Sergio
A1 Guzmán-Rolo, Germán
A1 Ballesteros-Pomar, María D
K1 Compliance
K1 Enteral formulas
K1 Enteral nutrition
K1 Gastroenterology
K1 Gastrointestinal diseases
K1 Nutrition
K1 Peptide-based formulas
AB Compliance in outpatients with gastrointestinal (GI) malabsorption is key in nutritional treatment. The objective of this study was to assess compliance in patients with GI impairment and malnutrition taking a high-calorie, high-protein, peptide-based oral nutritional supplement (ONS-PBD). A prospective, multicenter, observational study was conducted in 19 medical sites in Spain where ONS-PBD were prescribed as standard of care. Patients consumed ONS-PBD daily for 12 wk. Compliance was calculated as the percentage consumed of the prescribed amount of ONS per day. A total of 90 adult patients were included in the study, of whom 64 completed the 12-wk regimine. Mean compliance was 78.8% ± 24.5%. Risk of malnutrition decreased in 56.3% of patients at 12 wk, as measured with the malnutrition universal screening tool. A reduction in abdominal pain was observed and stool consistency improved, with a mean of 54.7% and 27.5%, respectively. Improvements in quality of life and a decrease in percentage of patients with severe functional impairment were observed. These data show that ONS-PBD compliance in malnourished patients with GI symptoms is high, reducing GI symptoms and improving patients' nutritional status.
YR 2022
FD 2022-05-21
LK http://hdl.handle.net/10668/22456
UL http://hdl.handle.net/10668/22456
LA en
DS RISalud
RD Apr 10, 2025